-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
-
-
-
-
-
-
-
Scotiabank Starts Gain Therapeutics (GANX) at Sector Outperform
-
-
-
-
-
-
-
Scotiabank Starts Zai Lab (ZLAB) at Sector Outperform
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA)
-
-
-
-
-
-
-
Cantor on Lyra Therapeutics (LYRA):'Better-Than-Expected BEACON Results Expand Opportunity for LYRA's CRS Platform'
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Ambrx Biopharma (AMAM) at Overweight
-
-
-
-
-
-
-
Cantor Fitzgerald Resumes Humanigen (HGEN) at Neutral, 'we remain on the sidelines until earnings visibility improves'
-
814 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

